Skip to content
City AM
Main navigation
Download free app
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • City of London BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      Labour will regret the Renters’ Rights Act

      Construction workers building a residential complex, symbolizing Labours push for renters rights legislation

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
      • The Punter
    • From our partners
      • The Morning Briefing: SBS x City AM
      • Aramco Team Series
      • LIV Golf
    • Featured

      NBA-EuroLeague talks at an impasse, adding uncertainty to bidding process

      Unfortunately, the article title and content are missing, making it difficult to generate a specific and contextually rele...

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      What’s on in London in May

      City skyline view with modern skyscrapers under a clear blue sky in May, reflecting urban growth and economic vibrancy

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Newsletters
  • Latest Paper
  • ISA Guide
  • Sign In
  • Sign Out
  • My Account

pharmaceuticals

  • Historic pharma precedent: Pfizer agrees to share its Covid-19 pill secrets with dozens of companies around the world

    November 16, 2021

    Pfizer’s new Covid-19 pill could be made available to more than half of the world’s population after the pharmaceutical giant signed a deal with a UN-backed group to allow other manufacturers to make its experimental pill. In a statement, Pfizer said it will grant a licence for the antiviral pill to the Geneva-based Medicines Patent [...]

  • Hikma expects trading to hit top end of guidance amid global vaccine growth

    November 4, 2021

    Hikma Pharmaceuticals today said it expects its full year performance to be closer to the top end of its guidance after its global vaccine products delivered strong growth. Delivering a trading update this morning, the London-based manufacturer projected full year generic pharmaceuticals revenue to be in the range of $810m to $830m. It also expects [...]

  • Pfizer enjoys 130 per cent revenue boost as Covid-19 vaccine roll out continues

    November 2, 2021

    Pharmaceutical giant and vaccine maker Pfizer has enjoyed a more than 130 per cent revenue boost in its third quarter, as the global vaccine drive continues. Pfizer pulled in a revenue of $24.1bn in its third quarter, up from $10.27bn in the same period last year. While revenue for its vaccine branch Comirnaty came in [...]

  • Socialising securely this winter

    October 29, 2021  |  Sponsored

    Life has begun to return to what feels like normal after so many months of the pandemic stopping us doing the things we love. But as we look forward to Christmas, it’s important we remember that the virus is still with us – and we still need to take sensible precautions to make sure we [...]

  • How’s vaccine inequality driving up global inflation?

    October 27, 2021  |  City Talk

    As the more highly vaccinated countries roll out Covid booster shots, other parts of the world are still struggling to get their first jab. The vaccine divide is more apparent in the emerging markets (EM). World organisations have voiced their concerns over “vaccine nationalism” whereby vaccine-exporting countries prioritise supply first for their own populations before [...]

  • Winter is coming – but we have the vaccines to keep us going

    October 26, 2021  |  Sponsored

    It’s been impossible not to notice the temperatures falling and the winter nights slowly drawing in. Whilst we can look forward to cosy Autumnal nights and frosty winter walks, that change in the weather also means it’s time to redouble our efforts to fight not just Covid-19, but flu, too.  Due to last year’s winter [...]

  • Covid-19 booster vaccinations: All your questions answered

    October 26, 2021

    A third Covid shot is coming your way this winter as two jabs may not give us sufficient protection, or at least not in the long term. Booster jabs are being offered as part of a ramped-up vaccine campaign in England and City A.M. caught up with Phil Day, superintendent pharmacist at Pharmacy2U, to discuss [...]

  • GSK waves goodbye to West London as breakup begins with new £120m HQ

    October 11, 2021

    GlaxoSmithKline will move its global headquarters to a new £120m site, as the pharmaceutical giant prepares to split up its empire into two separate businesses. The company today announced plans for a shiny new £120m headquarters in Weybridge for its new independent consumer healthcare company. Remaining pharmaceuticals and vaccine staff will also relocate from the [...]

  • Covid protection from Pfizer vaccine drops to 47 per cent six months after second dose

    October 5, 2021

    The effectiveness of the Pfizer/BioNTech SE vaccine in preventing infection by the coronavirus dropped to 47 per cent from 88 per cent six months after the second dose, according to data published that U.S. health agencies considered when deciding on the need for booster shots. Watch the full report.

  • New Covid vaccine formulation could be needed by mid-2022, says BioNTech boss

    October 4, 2021

    The boss of BioNTech, the German biotech firm behind the Pfizer Covid-19, has predicted that a new formulation for jabs will likely be needed by mid-2022. Scientists have warned that the virus could mutate in a way that means it is less resistant to vaccines. “This year [a different vaccine] is completely unneeded. But by [...]

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • …
  • Page 20
  • Next

Trending Articles

  • Jet fuel shortage looms as government scrambles to secure supplies

  • John Lewis hit with click-and-collect lawsuit 

  • JP Morgan shifts Paris jobs back to London in Brexit shake-up

  • Mark Kleinman: Is it lights out for Ovo Energy?

  • Pension industry 1-0 Torsten Bell

Subscribe

Subscribe to the City AM newsletter to have our top stories delivered directly to your inbox.

Subscribe
  • Got a story?
  • About City AM
  • Careers
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • News
  • Markets & Economics
  • Politics
  • Opinion
  • Life&Style
  • Personal Finance
  • City AM Events
  • City Winners
  • The Punter
  • Casino
  • City AM Puzzles

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
  • Newsletters
  • Advertising
  • About
  • Licensing
Copyright 2026 City AM Limited